PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-01-06

Date Title Company
06-Jan-2022 Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 RTW Investments Bolsters Leadership Team With Key Executive Appointments Businesswire
06-Jan-2022 NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC Businesswire
06-Jan-2022 Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 Global Furfuryl Alcohol Market (2021 to 2028) - Featuring Illovo Sugar Africa, Lenzing and Behran Oil Among Others - ResearchAndMarkets.com Businesswire
06-Jan-2022 Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio Businesswire
06-Jan-2022 Coronary Microcatheters Market to Witness Comprehensive Growth by 2031 MARKITWIRED Latest Market Reports
06-Jan-2022 TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation Businesswire
06-Jan-2022 Tissue Microarrayer Market to Partake Significant Development During 2029 MARKITWIRED Latest Market Reports
06-Jan-2022 Bluestar Genomics Announces Plans to Present at the 40th Annual J.P. Morgan Healthcare Conference January 12 at 4:30 p.m. Eastern Time Businesswire
06-Jan-2022 Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect Virtual Conference Businesswire
06-Jan-2022 i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules Businesswire
06-Jan-2022 Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors Businesswire
06-Jan-2022 Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability Businesswire
06-Jan-2022 RayzeBio to Present at J.P. Morgan Healthcare Virtual Conference on Tuesday, January 11, 2022 Businesswire
06-Jan-2022 Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI® (brexpiprazole) to Treat Schizophrenia in Pediatric Patients Ages 13-17 Businesswire
06-Jan-2022 Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline Businesswire
06-Jan-2022 Rallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022 Businesswire
06-Jan-2022 InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference Businesswire